ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H(HK:1541)
HK$3.28+0.25 (+8.44%)
HK:1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H ownership
HK$3.28
At close:+0.25 (+8.44%)
Want to see HK:1541 full AI Analyst Report?
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) Ownership - Who Owns ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H?
3 Followers
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) Ownership Overview
- 0.19% ETFs
- 99.81% Public Companies and Individual Investors
The ownership structure of ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) stock is a mix of institutional, retail, and individual investors. Approximately 0.19% of the company’s stock is owned by Institutional Investors, and 99.81% is owned by Public Companies and Individual Investors.
The ownership structure of ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) stock is a mix of institutional, retail, and individual investors. Approximately 0.19% of the company’s stock is owned by Institutional Investors, and 99.81% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| State Street | 802,000 | Institution | 0.19% | 307,968 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| SPDR Portfolio Emerging Markets ETF, SPEM ETF | 723,800 | Institution | 0.17% | 258,334 |
| SPDR S&P China ETF, GXC ETF | 78,200 | Institution | 0.02% | 27,911 |
FAQ
What percentage of ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.19% of ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) stock is held by institutional investors.
What percentage of ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.81% of ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) stock is held by public companies and individual investors.
Who owns the most shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541)?
State Street owns the most shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
